Immediate Impact
61 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Works of Elisa Anselmi being referenced
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER.
2017
Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian Experience
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Elisa Anselmi | 213 | 72 | 129 | 127 | 29 | 473 | |
| Michael Richter | 194 | 142 | 45 | 33 | 25 | 475 | |
| Francesco Dragoni | 136 | 81 | 48 | 27 | 28 | 574 | |
| Sharon West | 123 | 40 | 40 | 80 | 22 | 544 | |
| Ying-Chung Hong | 134 | 53 | 129 | 201 | 20 | 526 | |
| Mattia Bertoli | 74 | 127 | 131 | 28 | 27 | 500 | |
| Dominic Pantalony | 196 | 50 | 270 | 68 | 19 | 498 | |
| Feng Jung Sherida H. Woei-A-Jin | 230 | 47 | 101 | 15 | 38 | 523 | |
| J.P. Laporte | 207 | 54 | 170 | 19 | 32 | 567 | |
| Grace Egan | 157 | 122 | 17 | 59 | 19 | 512 | |
| J. H. Bourhis | 115 | 35 | 59 | 44 | 35 | 497 |
All Works
Login with ORCID to disown or claim papers
Loading papers...